Results 261 to 270 of about 101,476 (335)

Lymphocyte Activation in Cutaneous T-Cell Lymphoma

, 1995
Gary S. Wood
openalex   +1 more source

Indurated Plaques in an Otherwise Healthy Child

Pediatric Dermatology, EarlyView.
Edan Davidson, Sharon Merims, Rony Shreberk‐Hassidim, Dan Harlev, Stephanie Benshushan, Vered Molho‐Pessach   +5 more
wiley   +1 more source

Transient Leukemia in an Adult Dog With Cutaneous T‐Cell Lymphoma

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 5‐year‐old neutered female Beagle was presented with lethargy, vomiting, and reduced appetite. Physical examination revealed mild hyperthermia and a cutaneous thickness on the right thigh. Hematology showed marked leukocytosis and moderate thrombocytopenia, consisting of 80% of atypical circulating cells, initially suggesting acute ...
Raquel Moreira, Malgorzata Ossowska, Oriol Jornet‐Rius, Marta Santos, Francesco Cian   +4 more
wiley   +1 more source

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements

JAAD Case Reports
Gabriela Piñero-Crespo, BS, Alison H. Kucharik, MD, Wei-Shen Chen, MD, PhD, Dietrich Werner Idiáquez, MD, Josef Doenges, MD, Yumeng Zhang, MD, Lubomir Sokol, MD, PhD, Frank Glass, MD   +7 more
doaj  

Malignant and Normal T Cells Show Random Use of T-Cell Receptor ∝ Chain Variable Regions in Patients with Cutaneous T-Cell Lymphoma

, 1995
Jack Longley, Lynda Tyrrell, Shu-Zhuang Lu, JoAnn Farrell, Tie-Gang Ding, Shuling Yan, Denver Sallee, Peter Heald, Carole L. Berger, Robert E. Tigelaar, Richard L. Edelson   +10 more
openalex   +1 more source

Diagnostic Sensitivity of the PCR for Antigen Receptor Rearrangement (PARR) Assay for Canine Plasma Cell Tumors

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Background The PCR for Antigen Receptor Rearrangement (PARR) assay assesses clonality of a lymphoid population. Studies suggest PARR has decreased sensitivity for detecting clonality in canine plasma cell tumors (PCT) compared to lymphoma.
Emily D. Rout, Kacie Seymour, Robert Burnett, Cora Contreras, Anne C. Avery, A Russell Moore   +5 more
wiley   +1 more source

First report of indolent cutaneous T‐cell lymphoma in a fennec fox (Vulpes zerda)

Veterinary Dermatology, EarlyView.
A 10‐year‐old fennec fox (Vulpes zerda) was presented for multifocal regions of chronic alopecia and crusting. Cutaneous lymphocytosis was diagnosed through histopathological examination and immunohistochemical investigation. Clonal rearrangement of the T‐cell receptor gamma locus supports that lymphocytosis in this case is an indolent lymphoma ...
Kristen L. Shekelle, Alan R. Glassman, Kay A. Backues, Jennifer J. Kilburn, Desirae A. Foust‐Wheatcraft, Lauren Wood Stranahan   +5 more
wiley   +1 more source

Clinical significance and immune microenvironment association of cuproptosis‐related genes in pan‐cancer

Experimental Physiology, EarlyView.
Abstract Recent studies highlight the important roles of cuproptosis in cancer cells. However, the roles of the cuproptosis‐related genes (CRGs) in different cancers are still not fully understood. Comprehensive analysis was performed using open‐source bioinformatic platforms to disclose the expression profiles, prognostic significance, genomic and ...
Xinyu Ge, Kaijing Wang, Tian Zhao, Jinyi Wang, Jie Liu, Zhengliang Sun, Zhengjun Chai, Wen Zhang, Chengbao Li, Yan Xu, Guohan Chen   +10 more
wiley   +1 more source

Advances of Microneedles for Cancer Diagnosis and Therapy

MedComm – Biomaterials and Applications, Volume 4, Issue 3, September 2025.
Schematic diagram of microneedle for cancer diagnosis and treatment. ABSTRACT As the global incidence of cancer continues to rise, the need for innovative and precisive alternatives to conventional diagnostic and therapeutic methods has become increasingly urgent.
Chunli Yang, Li Zhang, Siyi Wang, Angxi Zhou, Run Tian, Maya Xiang, Ya Ren, Yang Yu, Rong Li, Maling Gou   +9 more
wiley   +1 more source

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

MedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi, Izuchukwu F. Okpalanwaka, Adenike Oyegbesan, Ebenezar Okoyeocha, Mariam Oladejo, Sikiru O. Imodoye   +5 more
wiley   +1 more source